这6个过度治疗方式,应告诫糖尿病患者

2018-10-20 佚名 :糖尿病家庭调养

糖尿病是一种因胰岛素绝对或相对不足导致,或靶组织细胞对胰岛素敏感性降低,导致血糖升高,出现尿糖,进而引起脂肪和蛋白质代谢紊乱的慢性进行性内分必代谢病。

糖尿病是一种因胰岛素绝对或相对不足导致,或靶组织细胞对胰岛素敏感性降低,导致血糖升高,出现尿糖,进而引起脂肪和蛋白质代谢紊乱的慢性进行性内分必代谢病。

糖尿病本身并不可怕,可怕的是它的并发症。而糖尿病患者在实际治疗中会有这两种极端的情况产生。

一是疏于治疗,达不达标根本不清楚。血糖想测时就测,因为没有不适症状;另一种是血糖控制过度,其结果极有可能发生低血糖,甚至有生命危险。那糖尿病过度治疗会有什么样的后果呢?

1.降糖过度

糖尿病患者往往比较担心高血糖,事实上,低血糖的危害也不小,轻者表现为心慌、出汗、头晕、瘫软无力,重者会严重损害中枢神经,导致意识障碍、昏迷乃至死亡。

而且,低血糖会使交感神经兴奋性增加,血管收缩、血压升高,而导致心脑血管意外(如心梗、脑血栓等)。另外,长期慢性低血糖,还会导致智力障碍甚至痴呆(特别是老年人)。

所以不宜将血糖降得过低,也不宜降得过快,否则会增加低血糖及心脑血管事件的风险。

2.限食过度

有的糖尿病患者对饮食治疗过于重视,过度地控制饮食,甚至不吃主食。这是错误的。饮食控制不等于“饥饿疗法”。

人体需要足够的热量供应,其次,主食中的碳水化合物是刺激胰 岛素分泌的天然物质,进食过少反而不利于血糖控制。

再有进食过少还会造成营养不良,研究证实,糖尿病足溃疡难以愈合就与营养不良有关。

最后,过度的节食还可能引起心理障碍。研究表明,体重过低与过胖,死亡率都会增加。尤其是中年以后的糖尿病患者,过于消瘦并无益处。

3.运动过度

运动疗法也是糖尿病的基础治疗之一,对糖尿病病人益处多多。可以增加机体热量消耗,改善胰岛素抵抗,降低血糖等等。

但要注意运动方式,需循序渐进,把握好运动强度,否则,将会适得其反。

激烈的运动(无氧运动)可兴奋交感神经,导致儿茶酚胺等胰岛素拮抗激素的分泌增加,使血糖升高。此外,运动时间过久、运动量过大(特别是在空腹状态下),将会显着增加发生低血糖反应的危险性。

另外,并非所有的糖尿病病患者都适合运动,例如,严重高血糖的病人、合并肾功能损害、有心功能不全或心绞痛,活动期眼底出血的患者都不适合运动。

4.焦虑过度

有的糖尿病患者确诊糖尿病后,十分焦虑,甚至影响到进食、睡觉。其结果就是血糖难以控制。

有的患者心理包袱很重,经常失眠,整日沉浸在焦虑悲观、自怨自艾中不能自拔,导致血糖升高或波动。

因此,一定要正确对待糖尿病,既不能不重视,也不能被它吓倒,力求处之泰然,保持心理平衡,以助于血糖的平稳控制。

5.药物依赖过度

糖尿病治疗强调综合治疗,除了药物,还需要生活方式干预,且所有降糖药都应在饮食和运动的基础上使用。

不重视饮食和运动,一味依靠增加降糖药来控制血糖,其结果是血糖控制不好,还会加快胰岛细胞走向衰竭。

其实这也包括对医生依赖过度,糖尿病患者的自我管理非常重要,其内容包括血糖自我监测和在此基础上的药物调整,以及如何选择饮食和运动,如何就医等。

6.减肥过度

肥胖是导致糖尿病的独立危险因素,超重者减肥,有助于改善胰岛素抵抗,增加降糖药物的疗效。但是,也并非越瘦越好,应当以符合标准体重为宜。

因为,过于消瘦会导致营养状况恶化,机体免疫功能以及抵抗力下降。而且,消瘦病人由于肝糖元储备降低,对低血糖的自我调节能力下降,使发生低血糖的危险性增加。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1975797, encodeId=b9a319e579748, content=<a href='/topic/show?id=fdbc6464eb2' target=_blank style='color:#2F92EE;'>#治疗方式#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64647, encryptionId=fdbc6464eb2, topicName=治疗方式)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Fri Jun 28 21:42:00 CST 2019, time=2019-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1745099, encodeId=bd3f1e45099db, content=<a href='/topic/show?id=321a940118c' target=_blank style='color:#2F92EE;'>#过度治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94011, encryptionId=321a940118c, topicName=过度治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e6435510490, createdName=jxrzshh, createdTime=Mon Jan 28 10:42:00 CST 2019, time=2019-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1474611, encodeId=e6ff14e461140, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Sun Oct 21 22:42:00 CST 2018, time=2018-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=350037, encodeId=d2cf35003e8d, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c33e2412978, createdName=1237db7em74暂无昵称, createdTime=Sun Oct 21 07:57:03 CST 2018, time=2018-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1041922, encodeId=e222104192217, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Sat Oct 20 10:42:00 CST 2018, time=2018-10-20, status=1, ipAttribution=)]
    2019-06-28 howi
  2. [GetPortalCommentsPageByObjectIdResponse(id=1975797, encodeId=b9a319e579748, content=<a href='/topic/show?id=fdbc6464eb2' target=_blank style='color:#2F92EE;'>#治疗方式#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64647, encryptionId=fdbc6464eb2, topicName=治疗方式)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Fri Jun 28 21:42:00 CST 2019, time=2019-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1745099, encodeId=bd3f1e45099db, content=<a href='/topic/show?id=321a940118c' target=_blank style='color:#2F92EE;'>#过度治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94011, encryptionId=321a940118c, topicName=过度治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e6435510490, createdName=jxrzshh, createdTime=Mon Jan 28 10:42:00 CST 2019, time=2019-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1474611, encodeId=e6ff14e461140, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Sun Oct 21 22:42:00 CST 2018, time=2018-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=350037, encodeId=d2cf35003e8d, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c33e2412978, createdName=1237db7em74暂无昵称, createdTime=Sun Oct 21 07:57:03 CST 2018, time=2018-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1041922, encodeId=e222104192217, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Sat Oct 20 10:42:00 CST 2018, time=2018-10-20, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1975797, encodeId=b9a319e579748, content=<a href='/topic/show?id=fdbc6464eb2' target=_blank style='color:#2F92EE;'>#治疗方式#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64647, encryptionId=fdbc6464eb2, topicName=治疗方式)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Fri Jun 28 21:42:00 CST 2019, time=2019-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1745099, encodeId=bd3f1e45099db, content=<a href='/topic/show?id=321a940118c' target=_blank style='color:#2F92EE;'>#过度治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94011, encryptionId=321a940118c, topicName=过度治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e6435510490, createdName=jxrzshh, createdTime=Mon Jan 28 10:42:00 CST 2019, time=2019-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1474611, encodeId=e6ff14e461140, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Sun Oct 21 22:42:00 CST 2018, time=2018-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=350037, encodeId=d2cf35003e8d, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c33e2412978, createdName=1237db7em74暂无昵称, createdTime=Sun Oct 21 07:57:03 CST 2018, time=2018-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1041922, encodeId=e222104192217, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Sat Oct 20 10:42:00 CST 2018, time=2018-10-20, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1975797, encodeId=b9a319e579748, content=<a href='/topic/show?id=fdbc6464eb2' target=_blank style='color:#2F92EE;'>#治疗方式#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64647, encryptionId=fdbc6464eb2, topicName=治疗方式)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Fri Jun 28 21:42:00 CST 2019, time=2019-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1745099, encodeId=bd3f1e45099db, content=<a href='/topic/show?id=321a940118c' target=_blank style='color:#2F92EE;'>#过度治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94011, encryptionId=321a940118c, topicName=过度治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e6435510490, createdName=jxrzshh, createdTime=Mon Jan 28 10:42:00 CST 2019, time=2019-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1474611, encodeId=e6ff14e461140, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Sun Oct 21 22:42:00 CST 2018, time=2018-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=350037, encodeId=d2cf35003e8d, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c33e2412978, createdName=1237db7em74暂无昵称, createdTime=Sun Oct 21 07:57:03 CST 2018, time=2018-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1041922, encodeId=e222104192217, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Sat Oct 20 10:42:00 CST 2018, time=2018-10-20, status=1, ipAttribution=)]
    2018-10-21 1237db7em74暂无昵称

    学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1975797, encodeId=b9a319e579748, content=<a href='/topic/show?id=fdbc6464eb2' target=_blank style='color:#2F92EE;'>#治疗方式#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64647, encryptionId=fdbc6464eb2, topicName=治疗方式)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Fri Jun 28 21:42:00 CST 2019, time=2019-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1745099, encodeId=bd3f1e45099db, content=<a href='/topic/show?id=321a940118c' target=_blank style='color:#2F92EE;'>#过度治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94011, encryptionId=321a940118c, topicName=过度治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e6435510490, createdName=jxrzshh, createdTime=Mon Jan 28 10:42:00 CST 2019, time=2019-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1474611, encodeId=e6ff14e461140, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Sun Oct 21 22:42:00 CST 2018, time=2018-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=350037, encodeId=d2cf35003e8d, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c33e2412978, createdName=1237db7em74暂无昵称, createdTime=Sun Oct 21 07:57:03 CST 2018, time=2018-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1041922, encodeId=e222104192217, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Sat Oct 20 10:42:00 CST 2018, time=2018-10-20, status=1, ipAttribution=)]
    2018-10-20 misszhang

    谢谢MedSci提供最新的资讯

    0

相关资讯

Brit J Cancer:睾丸癌主动脉辐射后,糖尿病风险研究

在儿童癌症幸存者中,虽然糖尿病风险在胰腺辐射接触后风险增加,其余睾丸癌(TC)生存者之间的相关性还没有调查。最近,有研究人员在2998名1年TC生存者中研究了糖尿病风险,他们均在50岁之前进行睾丸切除和/或放射治疗,时间均在1976年和2007年之间。研究人员将该群体的糖尿病发生率与普通人群比例进行了比较,并利用一个案例群体设计评估了治疗特异性糖尿病风险。研究发现,平均的跟踪调查时间为13.4年,

NEJM:糖尿病患者服用阿司匹林一级预防的疗效

由此可见,阿司匹林可用于预防没有明显心血管疾病的糖尿病患者严重血管事件,但它也会引起了大出血事件。绝对的好处在很大程度上与出血风险相抵消。

Cell Metab:意外!肥胖易增加糖尿病风险,背后有个关键分子

10月11日,《Cell Metabolism》期刊新发表了这一篇题为“Protein Kinase C Epsilon Deletion in Adipose Tissue, but Not in Liver, Improves Glucose Tolerance”的文章,揭示了一种关键酶——蛋白激酶C ε(protein kinase C epsilon,PKCε)在糖尿病中的代谢细节。这一研

NEJM:n-3脂肪酸补充剂对糖尿病的影响

由此可见,在没有心血管疾病证据的糖尿病患者中,接受n-3脂肪酸补充的患者与接受安慰剂治疗的患者之间发生严重血管事件的风险没有显著差异。

糖尿病“伤肾”了,该如何防?

糖尿病肾病是糖尿病最常见、最棘手的并发症之一,也是尿毒症透析的主要原因之一。据统计,糖尿病是目前我国慢性肾脏病的第一大病因,透析的第二大病因。那么,糖尿病患者如何才能防止肾损伤呢?

Cell Metab:颠覆认知!脂肪组织竟是糖尿病罪魁祸首!

研究人员将目光放到了每个人都有的组织—脂肪上。他们发现,只要去除糖尿病小鼠全身脂肪组织中的PKCε,小鼠就不会出现葡萄糖耐受不良,换言之,就是胰岛素抵抗消除!